-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Enanta Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.2M, a 34.1% increase year-over-year.
- Enanta Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$123M, a 7.78% increase year-over-year.
- Enanta Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$137M, a 10.8% decline from 2022.
- Enanta Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$124M, a 13% decline from 2021.
- Enanta Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$110M, a 163% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)